Furthermore, in a prospective examination comprising 194 patients exhibiting persistent LA and/or aCL, individuals with persistent LA who also tested positive for anti-β2GPI and anti-prothrombin antibodies exhibited the highest incidence of thrombosis, estimated at 8.4% per patient-year. This evidence concerns the gene F2 and deep vein thrombosis.